Sign in

CIK 0001736730

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Camp4 Therapeutics Corp

Sign in to watch
Ticker
CAMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-651-8867
Business address
100 TALCOTT AVENUE, SUITE 201, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$39,600
in 1 filing
Open-market sales, last 90 days
$1,760,126
in 3 filings

Net −$1,720,526. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Schwab Andrew J. −$1.8M Director sold 18% of stake
  2. Gold Kelly +$40K Chief Financial Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2024-10-15 AH Equity Partners Bio I, L.L.C. 10% owner Conversion +1,398,067 1,398,067
2024-10-15 AH Equity Partners Bio I, L.L.C. 10% owner Purchase +181,818 $11.00 $2.0M 1,579,885
2024-10-15 AH Equity Partners Bio I, L.L.C. 10% owner Purchase +545,454 $11.00 $6.0M 545,454
2024-10-15 AH Equity Partners Bio I, L.L.C. 10% owner Conversion · Series A Prime Preferred Stock −15,001,312 0
2024-10-15 AH Equity Partners Bio I, L.L.C. 10% owner Conversion · Series B Preferred Stock −679,163 0

Page 1 of 1 · 5 trades